San Diego-based Evofem Biosciences is a leading biopharmaceutical firm dedicated to bringing innovative solutions to women's sexual and reproductive health. The company is behind Phexxi, a vaginal gel designed to prevent unwanted pregnancies. However, they are also hard at work on another product: EVO100, an antimicrobial vaginal gel developed to prevent the transmission of urogenital infections like Chlamydia trachomatis and Neisseria gonorrhoeae in women. By creating products that fill unmet needs, Evofem Biosciences is paving the way for a healthier future for women worldwide.
Evofem Biosciences's ticker is EVFM
The company's shares trade on the NASDAQ stock exchange
They are based in San Diego, California
There are 51-200 employees working at Evofem Biosciences
It is evofem.com
Evofem Biosciences is in the Healthcare sector
Evofem Biosciences is in the Biotechnology industry
The following five companies are Evofem Biosciences's industry peers: